What HCA Healthcare, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 10 | 22 |
| Total trades | 28 | 88 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 58,513 | 302,122 |
| Disposed | 94,060 | 266,496 |
| Net activity | −35,547 | +35,626 |
Common stock only — 17 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rossitto Erica | SVP & Chief Nurse Executive | Nov 10 | Open-market sale · S | −3,500 | $505.81 | −$1.77M | 13,426 |
| Rossitto Erica | SVP & Chief Nurse Executive | Nov 06 | Withheld — tax / exercise cost · F | −6,601 | $494.99 | −$3.27M | 16,926 |
| Rossitto Erica | SVP & Chief Nurse Executive | Nov 06 | Exercise / conversion · M | +5,040 | $101.16 | +$510K | 23,527 |
| Rossitto Erica | SVP & Chief Nurse Executive | Nov 06 | Exercise / conversion · M | +8,080 | $81.96 | +$662K | 18,487 |
| Foster Jon M | EVP and COO | Nov 06 | Open-market sale · S | −1,484 | $491.98 | −$730K | 10,000 |
| Foster Jon M | EVP and COO | Nov 06 | Open-market sale · S | −6,302 | $493.58 | −$3.11M | 11,484 |
| Foster Jon M | EVP and COO | Nov 06 | Open-market sale · S | −7,595 | $494.91 | −$3.76M | 17,786 |
| Foster Jon M | EVP and COO | Nov 06 | Open-market sale · S | −2,692 | $495.85 | −$1.33M | 25,381 |
| Foster Jon M | EVP and COO | Nov 06 | Open-market sale · S | −1,066 | $496.92 | −$530K | 28,073 |
| Foster Jon M | EVP and COO | Nov 06 | Open-market sale · S | −1,684 | $498.00 | −$839K | 29,139 |
| Foster Jon M | EVP and COO | Nov 06 | Open-market sale · S | −890 | $498.97 | −$444K | 30,823 |
| Foster Jon M | EVP and COO | Nov 04 | Other Transaction · J | −16,142 | $503.53 | −$8.13M | 51,453 |
| Foster Jon M | EVP and COO | Nov 04 | Withheld — tax / exercise cost · F | −20,309 | $510.70 | −$10.4M | 15,571 |
| Foster Jon M | EVP and COO | Nov 04 | Exercise / conversion · M | +35,880 | $145.24 | +$5.21M | 35,880 |
| Foster Jon M | EVP and COO | Nov 04 | Open-market sale · S | −10,000 | $514.07 | −$5.14M | 0 |
| Frist Thomas F Iii | Director | Nov 04 | Other Transaction · J | +555,500 | $503.53 | +$280M | 32,282,889 |
| Frist Thomas F Iii | Director | Nov 04 | Other Transaction · J | −555,500 | $503.53 | −$280M | 32,282,889 |
| Schlosser Michael J | EVP and Chief Clinical Officer | Nov 04 | Open-market sale · S | −1,200 | $494.65 | −$594K | 1,443 |
| Elcan Patricia F | 10% owner | Nov 04 | Other Transaction · J | +886,871 | $503.53 | +$447M | 32,282,889 |
| Elcan Patricia F | 10% owner | Nov 04 | Other Transaction · J | −886,871 | $503.53 | −$447M | 32,282,889 |
Loading...